Skip to main content
. 2020 Mar 1;40(2):183–196. doi: 10.5851/kosfa.2020.e3

Table 3. Relative organ weight to body weight of mice fed PSW and LPSW.

Treatment Liver Kidneys Spleen Lungs Testes Brain
CON 3.57±0.054 1.33±0.047 0.26±0.014 0.52±0.028 0.58±0.021 0.78±0.030
SCO 3.42±0.086 1.30±0.019 0.24±0.009 0.47±0.025 0.59±0.005 0.79±0.023
THA10 3.50±0.082 1.35±0.022 0.25±0.014 0.49±0.022 0.59±0.034 0.76±0.029
PSW10 3.32±0.064 1.26±0.026 0.24±0.010 0.49±0.006 0.59±0.019 0.75±0.007
PSW40 3.37±0.100 1.26±0.040 0.25±0.009 0.53±0.014 0.58±0.031 0.74±0.016
LPSW100 3.41±0.082 1.36±0.036 0.28±0.011 0.50±0.010 0.61±0.014 0.74±0.009
LPSW400 3.43±0.057 1.34±0.024 0.26±0.014 0.49±0.007 0.59±0.016 0.76±0.014

Relative organ weight (%)=(Organ weight/Body weight)×100.

All values are mean±SE.

1)

Control (CON); scopolamine (SCO, 1 mg/kg body weight (B.W.), intraperitoneally (i.p.); tetrahydroaminoacridine 10 [THA 10, tacrine; 10 mg/kg B.W. per oral (p.o.) with SCO (i.p.)]; pig skin water extracts [PSW 10, 10 mg/kg B.W. (p.o.) with SCO (i.p.)]; PSW 40 [40 mg/kg B.W. (p.o.) with SCO (i.p.)]; low molecular weight pig skin water extracts [LPSW 100, 100 mg/kg B.W. (p.o.) with SCO (i.p.)]; LPSW 400 [400 mg/kg B.W. (p.o.) with SCO (i.p.)].